Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1534-1540

  Shrank, William H ^a   Asch, Steven M ^b,c,d   Joseph, George J ^b,e   Young, Henry N ^f   Ettner, Susan L ^g   Kholodenko, Yelena ^b   Glassman, Peter ^b,d,g   Kravitz, Richard L ^h,i  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h RAND ^*

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Out of pocket costs; Pharmacy benefit design; Prescription drugs

Indexed keywords

ARTICLE; COMPUTER; DRUG COST; DRUG FORMULARY; DRUG UTILIZATION; EMERGENCY PHYSICIAN; HUMAN; KNOWLEDGE; MEDICARE; PHARMACIST; PHARMACY BENEFIT MANAGER; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESPONSIBILITY; STATISTICAL ANALYSIS; SURGEON; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; DATA COLLECTION; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION FEES; SOCIAL RESPONSIBILITY;

EID: 33748324655     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H158     Document Type: Article

References (28)

1. Employer health benefits: 2004 summary of findings. Kaiser Family Foundation and Health Research and Educational Trust. www.kff.org/insurance/ 7148/sections/loader.cfm?url=/commonspot/security/getfile.cfm&PageID =46224 (accessed 2005 Jan 22).
2. Hoadley J. The effects of formularies and other cost management tools on access to medications: an analysis of the MMA and the final rule. For the Kaiser Family Foundation, www.kff.org/medicare/7299.cfm (accessed 2005 Apr 21).
3. Strunk BC, Reschovsky JD. Kinder and gentler: physicians and managed care, 1997-2001. Center for the Study of Health Systems Change, tracking report no. 5, November 2002. www.hschange.com/CONTENT/486/ ?topic=topic03 (accessed 2004 Aug 9).
4. Shrank WH, Ettner SL, Glassman P, Asch S. A bitter pill: formulary variability and the challenge for prescribing physicians. J Am Board Fam Pract 2004;17:401-7.
5. Shrank WH, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Am J Manag Care 2005; 11:16-22.
6. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 2004;19:638-45.
7. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred formulary medications improves adherence to chronic medications. Arch Intern Med 2006;166:332-7.
8. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care 2004;42:626-34.
9. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
10. Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients' out-of-pocket prescription costs. Arch Intern Med 2005;165:633-6.
11. Medical Board of California. 2004-2005 annual report, www.medbd.ca. gov/Pubs_Annualrept_2004-2005.pdf (accessed 2006 May 9).
12. SAS. Cary, NC: SAS Institute, 2005.
13. STATA 8.1 (Intercooled for Windows). College Station, TX: STATA, 2003.
14. Physician characteristics and distribution in the US. Chicago: American Medical Association, 2003-04ed.
15. Drug Evaluation Review Project. Oregon Health Sciences University. www.ohsu.edu/drugeffectiveness/reports/index.htm (accessed 2004 Aug 12).
16. Hillman AL, Pauly MV, Escarce JJ, et al. Financial incentives and drug spending in managed care. Health Affairs (Millwood) 1999;18:189-200.
17. Stuart B, Zacker C. Who bears the burden of Medicaid drug copayment policies? Health Affairs 1999;18:201-12.
18. Smith DG. The effects of copayments and generic substitution on the use and costs of prescription drugs. Inquiry 1993;30:189-98.
19. Reeder CE, Nelson AA. The differential impact of copayment on drug use in a Medicaid population. Inquiry 1985;22:396-403.
20. Harris BL, Stergachis A, Reid A. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization. Medical Care 1990;28:907-17.
21. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004;291:2344-50.
22. Bell DS, Marken RS, Meili RC, Wang J, Rosen M, Brook RH. Recommendations for comparing electronic prescribing systems: results of an expert consensus process. Health Aff (Millwood) 2004(suppl Web exclusives)W4:305-17.
23. Glassman PA, Tanielian T, Harris K, et al. Provider perceptions of pharmacy management: lessons from the military health system. Med Care 2004; 42:361-6.
24. California Medical Association. www.cmanet.org/publicdoc.cfm/10/1 (accessed 2006 May 9).
25. Frist WH. Health care in the 21st century. N Engl J Med 2005;352:267-72.
26. Doherty RB. Assessing the new Medicare prescription drug law. Ann Intern Med 2004;141:391-5. Epub 2004 Jul 12.
27. Shrank WH, Fox SA, Kirk A, et al. The effect of pharmacy benefit design on patient-physician communication about costs. J Gen Intern Med 2006;21:334-9.
28. Pear R. Pharmacists say drug plan threatens their livelihood. New York Times 2006 Mar 13.